Pharmaseed offers extensive CNS disease know-how and research services allowing a complete investigation of pharmacokinetics and pharmacodynamics of a drug in-vivo and a set of behavioural and analytical tests.
Pharmaseed offers an array of translational in vitro and in vivo models to establish proof-of-concept for potential treatments of CNS diseases. We provide essential information about the CNS efficacy and safety of any tested compound or technology for the determination of predicted CNS activity utilizing a battery of cognitive and neurological tests performed in a state-of-the-art and fully computerized behavioral laboratory.
With a broad array of tools at our disposal, including neurological, surgical and physiological models, biochemical assays, behavioral testing and preclinical neurotoxicological assays, Pharmaseed provides the most cost and time-effective pre-clinical services, with the highest standards of quality and accuracy. This provides our sponsors with significant information about primary and secondary outcomes, assisting them in planning the first-in-man stage.
These include various treatment indications:
- Complementary ex-vivo models for neurodegenerative diseases – organotypic brain slices